| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |